[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649525":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":27,"locations":27,"responsibleParty":28,"collaborators":27,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":34,"acronym":35,"eligibilityCriteria":36,"healthyVolunteers":32,"sex":37,"minAge":38,"maxAge":27,"enrollmentInfo":39,"targetDuration":27,"studyType":42,"phases":43,"briefSummary":45,"conditions":46,"keywords":27,"overallStatus":48,"whyStopped":27,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":27},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"tTIS group","EXPERIMENTAL","Following enrollment, patients underwent TIS treatment administered twice daily over five consecutive days, for a total of ten sessions. The stimulation was targeted at the periaqueductal gray (PAG) region contralateral to the side of pain. Assessments were conducted before treatment (T0) and immediately after the treatment course (T1), evaluating pain perception, emotional changes, and quality of life. Additionally, local and whole-brain mechanisms were examined using TIS-EEG and fMRI.",[13],"Device: Transcranial temporal interference stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham group","SHAM_COMPARATOR","The sham group followed the same procedure as the TIS group. However, the electrical current was only delivered in a 30-second ramp-up at the beginning and a 30-second ramp-down at the end of each session to replicate the initial peripheral sensation without providing sustained therapeutic stimulation.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Transcranial temporal interference stimulation","tTIS was applied to the PAG contralateral to the pain side for a duration of 20 minutes, comprising a 30-second ramp-up phase and a 30-second ramp-down phase.",[15,9],[26],"tTIS",null,{"type":29,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100649525","effects-and-mechanisms-of-temporal-interference-stimulation-tis-on-neuropathic-pain-100649525",false,"NCT07735975","Effects and Mechanisms of Temporal Interference Stimulation (TIS) on Neuropathic Pain","TIS","Inclusion Criteria:\n\n* IASP diagnosis of peripheral neuropathic pain;\n* At least one month after the onset of pain;\n* At least moderate pain intensity (≥ 3 assessed by VAS or NRS);\n* 18 years or older;\n* Stable medical treatment from 2 weeks before allocation to the end of the trial;\n* Willing to receive TIS treatment and capable of fulfilling clinical assessments.\n\nExclusion Criteria:\n\n* Contradictions to TIS treatment, such as metal implants or seizure;\n* Serious psychiatric disorder (Hamilton Depression Rating Scale score ≥ 35 or Hamilton Anxiety Rating Scale score ≥ 29);\n* Aphasia or cognitive disorders (Mini mental state examination ≤ 24);\n* Severe clinical disorders caused by tumor or other conditions;\n* Severe cardiopulmonary dysfunction or extreme weakness;\n* History of substance abuse (alcohol, drugs).","ALL","18 Years",{"count":40,"type":41},60,"ESTIMATED","INTERVENTIONAL",[44],"NA","This study employs temporal interference stimulation (tTIS) to investigate the analgesic effects of tTIS on neuropathic pain and monitor changes in neural plasticity, and explore the dynamic relationship between analgesic efficacy and neural plasticity, thereby providing new strategies for the treatment of neuropathic pain.",[47,26],"Neuropathic Pain","NOT_YET_RECRUITING","2026-07-29",{"date":51,"type":52},"2026-07-30","ACTUAL",{"date":54,"type":41},"2026-08-01",{"date":56,"type":41},"2028-01-31",{"name":5,"class":6}]